Related Experiment Videos
Minocycline related lupus
C Masson1, A Chevailler, C Pascaretti
1Service de Rhumatologie, CHU d'Angers, France.
The Journal of Rheumatology
|December 1, 1996
Summary
Minocycline can trigger lupus-like symptoms, particularly in patients with HLA-DR2. This suggests a potential link between this antibiotic and autoimmune rheumatic disease development.
Area of Science:
- Rheumatology
- Dermatology
- Pharmacology
Background:
- Identifying triggers for lupus-like symptoms is crucial for managing rheumatic diseases.
- Minocycline is an antibiotic commonly prescribed for acne.
- Human Leukocyte Antigen (HLA)-DR2 is a genetic marker associated with certain autoimmune conditions.
Observation:
- A young patient with HLA-DR2 experienced recurrent rheumatic symptoms upon minocycline prescription for acne.
- The patient developed lupus-like symptoms each time minocycline was administered.
- Eight additional cases of minocycline-induced lupus were identified in the literature.
Findings:
- Minocycline acts as a potential trigger for drug-induced lupus erythematosus.
- The presence of HLA-DR2 may predispose individuals to developing minocycline-related lupus.
- Recurrence of symptoms upon re-exposure confirms the causal relationship.
Implications:
- This finding highlights the importance of considering minocycline as a potential cause of lupus-like symptoms.
- Physicians should be vigilant for drug-induced lupus in patients prescribed minocycline, especially those with HLA-DR2.
- Further research into the mechanisms of minocycline-induced autoimmunity is warranted.